Skip to main content
SpringerLink
Log in

Nebennierenrindenkarzinom

  • Chapter
Uroonkologie

  • 1396 Accesses

Zusammenfassung

Die Inzidenz des seltenen Nebennierenrindenkarzinoms wird mit etwa 1–2/1 Mio./Jahr angegeben. Der häufig sehr aggressive Tumor führt zu etwa 0,2% aller Todesfälle aufgrund maligner Erkrankungen. Die Altersverteilung ist bimodal mit einem ersten Gipfel im Kindesalter und einem zweiten Gipfel in der 5.–6. Dekade. Frauen und Männer sind etwa im Verhältnis 1,5 ∶ 1 betroffen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abraham J, Bakke S, Rutt A et al. (2002) A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine and etoposide with daily mitotane as a P-glycoprotein antagonist. Cancer 94: 2333–2343

    Article  CAS  PubMed  Google Scholar 

  • Allolio B, Hahner S, Weismann D et al. (2004) Management of adrenocortical carcinoma. Clin Endocrinol (Oxf) 60: 273–287

    Article  Google Scholar 

  • Assie G, Antoni G, Tissier F et al. (2007) Prognostic parameters of metastatic adrenocortical carcinoma. J Clin Endocrinol Metab 92 (1): 148–54

    Article  CAS  PubMed  Google Scholar 

  • Baudin E, Pellegriti G, Bonnay M et al. (2001) Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p′DDD) levels on the treatment of patients with adrenocortical carcinoma. Cancer 92: 1385–1392

    Article  CAS  PubMed  Google Scholar 

  • Becherer A, Vierhapper H, Potzi C et al. (2001) FDG-PET in adrenocortical carcinoma. Cancer Biother Radiopharm 16: 289–295

    Article  CAS  PubMed  Google Scholar 

  • Berruti A, Terzolo M, Pia A et al. (1998) Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer. Cancer 83: 2194–2200

    Article  CAS  PubMed  Google Scholar 

  • Caoili EM, Korobkin M, Francis IR et al. (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175: 1411–1415

    CAS  PubMed  Google Scholar 

  • Fassnacht M, Hahner S, Banfelder N et al. (2005) Diagnostik und Therapie des Nebennierenrinden-Karzinoms. DÄ 102: 1670–1675

    Google Scholar 

  • Fassnacht M, Hahner S, Polat B et al. (2006) Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma. J Clin Endocrinol Metab 91 (11): 4501–4

    Article  CAS  PubMed  Google Scholar 

  • Hahner S, Stuermer A, Kreissl M et al. (2008) [123 I]lodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. J Clin Endocrinol Metab 93 (6): 2358–65

    Article  CAS  PubMed  Google Scholar 

  • Khan TS, Imam H, Juhlin C et al. (2000) Streptozocin and o,p′DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use. Ann Oncol 11: 1281–1287

    Article  CAS  PubMed  Google Scholar 

  • Pena CS, Boland GW, Hahn PF et al. (2000) Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217: 798–802

    CAS  PubMed  Google Scholar 

  • Quinkler M, Hahner S, Wortmann S et al. (2008) Treatment of advanced adrenocortical carcinoma with erlotinib plus gemcitabine. J Clin Endocrinol Metab 93 (6): 2057–62

    Article  CAS  PubMed  Google Scholar 

  • Saeger W (2000) Histopathological classification of adrenal tumours. Eur J Clin Invest 30 Suppl 3: 58–62

    Article  PubMed  Google Scholar 

  • Schteingart DE, Doherty GM, Gauger PG et al. (2005) Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12 (3): 667–80

    Article  CAS  PubMed  Google Scholar 

  • Terzolo M, Ali A, Osella G et al. (2000) The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. Eur J Endocrinol 142: 611–617

    Article  CAS  PubMed  Google Scholar 

  • Terzolo M, Angeli A, Fassnacht M et al. (2007) Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 356 (23): 2372–80

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Endokrinologie, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen

    Prof. Dr. med. Stephan Petersenn

  2. Klinik für Nuklearmedizin, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen

    Prof. Dr. med. Dr. rer. nat. Andreas Bockisch

  3. Klinik u. Poliklinik für Urologie, Universitätsklinikum Essen, Hufelandstr. 55, 45122, Essen

    Prof. Dr. med. Herbert Rübben

  4. Abt. für Endokrinologie, Universitätsklinikum Essen, Hufelandstr. 55, 45122, Essen

    Prof. Dr. med. Klaus Mann

Authors
  1. Prof. Dr. med. Stephan Petersenn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Dr. rer. nat. Andreas Bockisch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. med. Herbert Rübben
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prof. Dr. med. Klaus Mann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen

    Herbert Rübben (Direktor der Klinik und Poliklinik für Urologie) (Direktor der Klinik und Poliklinik für Urologie)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Petersenn, S., Bockisch, A., Rübben, H., Mann, K. (2009). Nebennierenrindenkarzinom. In: Rübben, H. (eds) Uroonkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01382-9_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-01382-9_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-01381-2

  • Online ISBN: 978-3-642-01382-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation